These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26886616)

  • 1. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
    He XK; Su TT; Si JM; Sun LM
    Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.
    Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.
    Tian S; Lei HB; Liu YL; Chen Y; Dong WG
    Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
    Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
    Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
    Wang Q; Shi M
    Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
    Wang Y; Xiao J; Zhao Y; Du S; Du J
    Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
    Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
    PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis.
    Yang WT; Yang HJ; Zhou JG; Liu JL
    Int J Colorectal Dis; 2020 Nov; 35(11):2117-2131. PubMed ID: 32720184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
    Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
    J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of metformin on colorectal carcinoma in type 2 diabetes mellitus patients: a Markov model analysis].
    Su T; Liao B; Dong Y; Peng Z; Zhou Q; Li B; Peng S; Zhang N
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):689-693. PubMed ID: 28643317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
    Shuai Y; Li C; Zhou X
    Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of metformin use and cancer incidence: a systematic review and meta-analysis.
    O'Connor L; Bailey-Whyte M; Bhattacharya M; Butera G; Hardell KNL; Seidenberg AB; Castle PE; Loomans-Kropp HA
    J Natl Cancer Inst; 2024 Apr; 116(4):518-529. PubMed ID: 38291943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
    Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.
    Shami JJP; Yan VKC; Wei Y; Alwafi H; Blais JE; Wan E; Wong CKH; Cheung KS; Leung WK; Wong MCS; Wong ICK; Chan EW
    J Intern Med; 2023 Mar; 293(3):371-383. PubMed ID: 36382924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.
    Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM
    Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
    Xie H; Li M; Zheng Y
    Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
    Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.